BloggingStocks

Early analyst calls: DNA, JNJ

Posted Aug 15th 2008 7:20AM by Douglas McIntyre
Filed under: Before the bell, Analyst upgrades and downgrades, Johnson and Johnson (JNJ), Genentech Inc (DNA)

Goldman Sachs downgraded Daimler (NYSE: DAI) to Neutral from Buy, according to MarketWatch.

Citigroup downgraded Genentech (NYSE: DNA) to Hold from Buy, according to Briefing.com. The news service also writes that UBS downgraded Johnson & Johnson (NYSE: JNJ) to Hold from Buy.

Priceline.com (NASDAQ: PCLN) was raised to Buy at Citigroup, according to Briefing.com. The financial site also reports that Harman (NYSE: HAR) was cut to Neutral at Baird.

Tags: DAI, DNA, har, inthenews, JNJ, pcln

All contents copyright © 2003-2008, Weblogs, Inc. All rights reserved

BloggingStocks is a member of the Weblogs, Inc. Network. Privacy Policy, Terms of Service, Notify AOL